Newron to acquire NeuroNova AB

Newron Pharmaceuticals SpA of Italy is to acquire NeuroNova AB, a privately-owned Swedish company that specialises in neurogenesis and which has early-stage compounds for Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Italy